Concepedia

Lakshmi Nayak

LN

Statistics

Publications

75

Citations

8.6K

H-Index

40

Active since

1981

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Massachusetts General Hospital

Center for Neuro-Oncology

Lakshmi Nayak is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and neuro-oncology.

Publications per year

1981–2025

75

Publications

75

Epidemiology of Brain Metastases

Lakshmi Nayak, Eudocia Q. Lee, Patrick Y. Wen · Current Oncology Reports · 2011 · 1.4K citations

Medicine, Neurology, Oncology +12

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Nicholas Butowski, Howard Colman, John de Groot et al. · Neuro-Oncology · 2015 · 580 citations · Full text

Medicine, Oncology, Pharmacology +17

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce et al. · Blood · 2017 · 459 citations · Full text

Medicine, Immunology, Oncology +16

1–5 of 75